Literature DB >> 3875096

Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma.

R S Accolla, G Carra, J Guardiola.   

Abstract

Raji, a human B-lymphoma cell line, expresses high levels of class II (Ia) antigens. The expression of Ia antigens is totally abolished at the level of specific mRNA accumulation in RJ 2.2.5, a variant cell line derived from Raji after mutagenesis and immunoselection. We report here that the human Ia antigen expression can be restored in interspecies somatic cell hybrids between RJ 2.2.5 cells and BALB/c-derived M12.4.1 (I-A+, I-E+) B-lymphoma cells. Two hybrid clones were studied in detail. In both clones Ia molecules of the DR and NG2 type were easily detected by cell surface immunofluorescence and specific immunoprecipitation. In contrast, the DQ1 molecules were not detected with the above technique. DNA hybridization experiments using specific probes indicated that alpha-chain DR and beta-chain DQ genes were present in the hybrids. However, RNA hybridization experiments revealed that beta-chain DQ mRNA was present in the hybrids at very low amount compared to alpha-chain DR-specific mRNA. These results indicate that at least several genes of the class II gene cluster are coordinately regulated by trans-acting factor(s) that operate across species barriers. The basis of the mechanisms controlling the expression of class II antigens in these human-mouse hybrids might be related to the extinction (lack of expression) or activation of tissue-specific traits that take place when genomes of cells of dissimilar developmental potentials are brought together.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875096      PMCID: PMC390516          DOI: 10.1073/pnas.82.15.5145

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Selective activation of human beta-but not gamma-globin gene in human fibroblast x mouse erythroleukaemia cell hybrids.

Authors:  M C Willing; A W Nienhuis; W F Anderson
Journal:  Nature       Date:  1979-02-15       Impact factor: 49.962

Review 5.  The human Ia system: an overview.

Authors:  R S Accolla; A Moretta; S Carrel
Journal:  Semin Hematol       Date:  1984-10       Impact factor: 3.851

6.  Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant.

Authors:  P Gladstone; D Pious
Journal:  Somatic Cell Genet       Date:  1980-03

7.  Stable variants affecting B cell alloantigens in human lymphoid cells.

Authors:  D Pious
Journal:  Nature       Date:  1978-02-02       Impact factor: 49.962

8.  Orientation of major histocompatibility (MHC) genes relative to the centromere of human chromosome 6.

Authors:  E Bakker; P L Pearson; P Meera Khan; G M Schreuder; K Madan
Journal:  Clin Genet       Date:  1979-02       Impact factor: 4.438

9.  Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines.

Authors:  R S Accolla; S Carrel; J P Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Externally disposed plasma membrane proteins. I. Enzymatic iodination of mouse L cells.

Authors:  A L Hubbard; Z A Cohn
Journal:  J Cell Biol       Date:  1975-02       Impact factor: 10.539

View more
  41 in total

1.  Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

Authors:  M Bull; A van Hoef; J Gorski
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

2.  Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.

Authors:  L Zhu; P P Jones
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

Review 3.  A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.

Authors:  R S Accolla; P Dellabona; L Scarpellino; G Carra; S Sartoris
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  Effect of the AIR-1 locus on the activation of an enhancerless HLA-DQA1 promoter.

Authors:  M N Ombra; G Del Pozzo; C Perfetto; A Maffei; J Guardiola
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  The X boxes from promoters of HLA class II B genes at different loci do not complete for nuclear protein-specific binding.

Authors:  E Turco; B J Manfras; L Ge; W A Rudert; M Trucco
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors.

Authors:  R L Dedrick; P P Jones
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 7.  Genetics of HLA class II regulation.

Authors:  C R Hume; J S Lee
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

8.  The MHC class II E beta promoter: a complex arrangement of positive and negative elements determines B cell and interferon-gamma (IFN-gamma) regulated expression.

Authors:  D Thanos; M Gregoriou; D Stravopodis; K Liapaki; T Makatounakis; J Papamatheakis
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

Review 9.  Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.

Authors:  Roberto S Accolla; Giovanna Tosi
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-07       Impact factor: 4.147

10.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.